-
1
-
-
0028630616
-
Teratogen update: angiotensin-converting enzyme inhibitors
-
Barr M Jr. Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 1994; 50: 399-409.
-
(1994)
Teratology
, vol.50
, pp. 399-409
-
-
Barr Jr., M.1
-
2
-
-
25144461158
-
Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis
-
Gribouval O, Gonzales M, Neuhaus T, Aziza J, Bieth E, Laurent N, Bouton JM, Feuillet F, Makni S, Ben AH, Laube G, Delezoide AL, Bouvier R, Dijoud F, Ollagnon-Roman E, Roume J, Joubert M, Antignac C, Gubler MC. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 2005; 37: 964-968.
-
(2005)
Nat Genet
, vol.37
, pp. 964-968
-
-
Gribouval, O.1
Gonzales, M.2
Neuhaus, T.3
Aziza, J.4
Bieth, E.5
Laurent, N.6
Bouton, J.M.7
Feuillet, F.8
Makni, S.9
Ben, A.H.10
Laube, G.11
Delezoide, A.L.12
Bouvier, R.13
Dijoud, F.14
Ollagnon-Roman, E.15
Roume, J.16
Joubert, M.17
Antignac, C.18
Gubler, M.C.19
-
3
-
-
78751673077
-
Angiotensin II receptor blocker induced fetopathy: 7 Cases
-
Hunseler C, Paneitz A, Friedrich D, Lindner U, Oberthuer A, Korber F, Schmitt K, Welzing L, Muller A, Herkenrath P, Hoppe B, Gortner L, Roth B, Kattner E, Schaible T. Angiotensin II receptor blocker induced fetopathy: 7 Cases. Klin Padiatr 2011; 223: 10-14.
-
(2011)
Klin Padiatr
, vol.223
, pp. 10-14
-
-
Hunseler, C.1
Paneitz, A.2
Friedrich, D.3
Lindner, U.4
Oberthuer, A.5
Korber, F.6
Schmitt, K.7
Welzing, L.8
Muller, A.9
Herkenrath, P.10
Hoppe, B.11
Gortner, L.12
Roth, B.13
Kattner, E.14
Schaible, T.15
-
5
-
-
42149163520
-
Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected
-
Kato K, Okuda M, Ishikawa H, Takahashi T, Hirahara F. Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected. J Obstet Gynaecol Res 2008; 34: 242-246.
-
(2008)
J Obstet Gynaecol Res
, vol.34
, pp. 242-246
-
-
Kato, K.1
Okuda, M.2
Ishikawa, H.3
Takahashi, T.4
Hirahara, F.5
-
6
-
-
65649147113
-
Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists
-
Sinelli MT, Cattarelli D, Cortinovis S, Maroccolo D, Chirico G. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists. Pediatr Med Chir 2008; 30: 306-308.
-
(2008)
Pediatr Med Chir
, vol.30
, pp. 306-308
-
-
Sinelli, M.T.1
Cattarelli, D.2
Cortinovis, S.3
Maroccolo, D.4
Chirico, G.5
-
7
-
-
70450061729
-
A case report of prenatal exposure to rosuvastatin and telmisartan
-
Trakadis Y, Blaser S, Hahn CD, Yoon G. A case report of prenatal exposure to rosuvastatin and telmisartan. Paediatr Child Health 2009; 14: 450-452.
-
(2009)
Paediatr Child Health
, vol.14
, pp. 450-452
-
-
Trakadis, Y.1
Blaser, S.2
Hahn, C.D.3
Yoon, G.4
-
8
-
-
67349103080
-
Angiotensin II receptor blockers in pregnancy: a report of five cases
-
Gersak K, Cvijic M, Cerar LK. Angiotensin II receptor blockers in pregnancy: a report of five cases. Reprod Toxicol 2009; 28: 109-112.
-
(2009)
Reprod Toxicol
, vol.28
, pp. 109-112
-
-
Gersak, K.1
Cvijic, M.2
Cerar, L.K.3
-
9
-
-
67650326927
-
Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker
-
Miura K, Sekine T, Iida A, Takahashi K, Igarashi T. Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker. Pediatr Nephrol 2009; 24: 1235-1238.
-
(2009)
Pediatr Nephrol
, vol.24
, pp. 1235-1238
-
-
Miura, K.1
Sekine, T.2
Iida, A.3
Takahashi, K.4
Igarashi, T.5
-
10
-
-
70349484423
-
Warnings against candesartan in pregnancy are not implemented in physicians' practice
-
Borthen C, Oglaend B, Eggeboe T, Ellingsen CL, Schjott J. Warnings against candesartan in pregnancy are not implemented in physicians' practice. Eur J Obstet Gynecol Reprod Biol 2009; 146: 235.
-
(2009)
Eur J Obstet Gynecol Reprod Biol
, vol.146
, pp. 235
-
-
Borthen, C.1
Oglaend, B.2
Eggeboe, T.3
Ellingsen, C.L.4
Schjott, J.5
-
11
-
-
77951621931
-
Reversible fetal renal failure after maternal treatment with candesartan: a case report
-
Munk PS, von Brandis P, Larsen AI. Reversible fetal renal failure after maternal treatment with candesartan: a case report. Reprod Toxicol 2010; 29: 381-382.
-
(2010)
Reprod Toxicol
, vol.29
, pp. 381-382
-
-
Munk, P.S.1
von Brandis, P.2
Larsen, A.I.3
-
12
-
-
77953465542
-
Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
-
Haaland K. Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome. J Headache Pain 2010; 11: 167-169.
-
(2010)
J Headache Pain
, vol.11
, pp. 167-169
-
-
Haaland, K.1
-
14
-
-
31544445756
-
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists
-
Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006; 82: 23-28.
-
(2006)
Early Hum Dev
, vol.82
, pp. 23-28
-
-
Quan, A.1
-
15
-
-
48349134531
-
Using observational cohort data for studying drug effects on pregnancy outcome - methodological considerations
-
Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome - methodological considerations. Reprod Toxicol 2008; 26: 36-41.
-
(2008)
Reprod Toxicol
, vol.26
, pp. 36-41
-
-
Schaefer, C.1
Ornoy, A.2
Clementi, M.3
Meister, R.4
Weber-Schoendorfer, C.5
-
16
-
-
0141893974
-
Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity
-
Schaefer C. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res A Clin Mol Teratol 2003; 67: 591-594.
-
(2003)
Birth Defects Res A Clin Mol Teratol
, vol.67
, pp. 591-594
-
-
Schaefer, C.1
-
17
-
-
33746533123
-
Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system
-
Lacoste M, Cai Y, Guicharnaud L, Mounier F, Dumez Y, Bouvier R, Dijoud F, Gonzales M, Chatten J, Delezoide AL, Daniel L, Joubert M, Laurent N, Aziza J, Sellami T, Amar HB, Jarnet C, Frances AM, ikha-Dahmane F, Coulomb A, Neuhaus TJ, Foliguet B, Chenal P, Marcorelles P, Gasc JM, Corvol P, Gubler MC. Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system. J Am Soc Nephrol 2006; 17: 2253-2263.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2253-2263
-
-
Lacoste, M.1
Cai, Y.2
Guicharnaud, L.3
Mounier, F.4
Dumez, Y.5
Bouvier, R.6
Dijoud, F.7
Gonzales, M.8
Chatten, J.9
Delezoide, A.L.10
Daniel, L.11
Joubert, M.12
Laurent, N.13
Aziza, J.14
Sellami, T.15
Amar, H.B.16
Jarnet, C.17
Frances, A.M.18
ikha-Dahmane, F.19
Coulomb, A.20
Neuhaus, T.J.21
Foliguet, B.22
Chenal, P.23
Marcorelles, P.24
Gasc, J.M.25
Corvol, P.26
Gubler, M.C.27
more..
-
18
-
-
4043082810
-
The role of angiotensin II in kidney embryogenesis and kidney abnormalities
-
Sequeira Lopez ML, Gomez RA. The role of angiotensin II in kidney embryogenesis and kidney abnormalities. Curr Opin Nephrol Hypertens 2004; 13: 117-122.
-
(2004)
Curr Opin Nephrol Hypertens
, vol.13
, pp. 117-122
-
-
Sequeira Lopez, M.L.1
Gomez, R.A.2
-
19
-
-
0034822751
-
Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review
-
Tabacova SA, Kimmel CA. Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review. Reprod Toxicol 2001; 15: 467-478.
-
(2001)
Reprod Toxicol
, vol.15
, pp. 467-478
-
-
Tabacova, S.A.1
Kimmel, C.A.2
-
20
-
-
0032790833
-
Problems of using data from Teratology Information Services (TIS) to identify putative teratogens
-
Martinez-Frias ML, Rodriguez-Pinilla E. Problems of using data from Teratology Information Services (TIS) to identify putative teratogens. Teratology 1999; 60: 54-55.
-
(1999)
Teratology
, vol.60
, pp. 54-55
-
-
Martinez-Frias, M.L.1
Rodriguez-Pinilla, E.2
-
21
-
-
0034059165
-
More on data from teratogen information systems (TIS)
-
Ornoy A, Mastroiacovo P. More on data from teratogen information systems (TIS). Teratology 2000; 61: 327-328.
-
(2000)
Teratology
, vol.61
, pp. 327-328
-
-
Ornoy, A.1
Mastroiacovo, P.2
-
22
-
-
0034941331
-
Selection bias in Teratology Information Service pregnancy outcome studies
-
Johnson KA, Weber PA, Jones KL, Chambers CD. Selection bias in Teratology Information Service pregnancy outcome studies. Teratology 2001; 64: 79-82.
-
(2001)
Teratology
, vol.64
, pp. 79-82
-
-
Johnson, K.A.1
Weber, P.A.2
Jones, K.L.3
Chambers, C.D.4
-
23
-
-
33748119834
-
In utero losartan withdrawal and subsequent development of fetal inferior vena cava thrombosis
-
Bakkum JN, Brost BC, Johansen KL, Johnston BW, Watson WJ. In utero losartan withdrawal and subsequent development of fetal inferior vena cava thrombosis. Obstet Gynecol 2006; 108: 739-740.
-
(2006)
Obstet Gynecol
, vol.108
, pp. 739-740
-
-
Bakkum, J.N.1
Brost, B.C.2
Johansen, K.L.3
Johnston, B.W.4
Watson, W.J.5
-
24
-
-
0036841147
-
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7)
-
Kucharewicz I, Pawlak R, Matys T, Pawlak D, Buczko W. Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7). Hypertension 2002; 40: 774-779.
-
(2002)
Hypertension
, vol.40
, pp. 774-779
-
-
Kucharewicz, I.1
Pawlak, R.2
Matys, T.3
Pawlak, D.4
Buczko, W.5
-
26
-
-
34547192579
-
Prenatal thrombosis of the inferior vena cava and the renal veins
-
Smorgick N, Herman A, Wiener Y, Halperin R, Sherman D. Prenatal thrombosis of the inferior vena cava and the renal veins. Prenat Diagn 2007; 27: 603-607.
-
(2007)
Prenat Diagn
, vol.27
, pp. 603-607
-
-
Smorgick, N.1
Herman, A.2
Wiener, Y.3
Halperin, R.4
Sherman, D.5
-
27
-
-
0242317249
-
Defective embryogenesis with angiotensin II receptor antagonists in pregnancy
-
Cox RM, Anderson JM, Cox P. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy. BJOG 2003; 110: 1038-1040.
-
(2003)
BJOG
, vol.110
, pp. 1038-1040
-
-
Cox, R.M.1
Anderson, J.M.2
Cox, P.3
-
28
-
-
0036670377
-
AT(1)-receptor blockers: differences that matter
-
Gradman AH. AT(1)-receptor blockers: differences that matter. J Hum Hypertens 2002; 16 (Suppl. 3): S9-S16.
-
(2002)
J Hum Hypertens
, vol.16
, Issue.SUPPL. 3
-
-
Gradman, A.H.1
-
29
-
-
33744966030
-
Major congenital malformations after first-trimester exposure to ACE inhibitors
-
Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443-2451.
-
(2006)
N Engl J Med
, vol.354
, pp. 2443-2451
-
-
Cooper, W.O.1
Hernandez-Diaz, S.2
Arbogast, P.G.3
Dudley, J.A.4
Dyer, S.5
Gideon, P.S.6
Hall, K.7
Ray, W.A.8
-
30
-
-
79956349425
-
Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers
-
Diav-Citrin O, Shechtman S, Halberstadt Y, Finkel-Pekarsky V, Wajnberg R, Arnon J, Di GE, Clementi M, Ornoy A. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol 2011; 31: 540-545.
-
(2011)
Reprod Toxicol
, vol.31
, pp. 540-545
-
-
Diav-Citrin, O.1
Shechtman, S.2
Halberstadt, Y.3
Finkel-Pekarsky, V.4
Wajnberg, R.5
Arnon, J.6
Di, G.E.7
Clementi, M.8
Ornoy, A.9
-
31
-
-
39649092947
-
Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy
-
Bowen ME, Ray WA, Arbogast PG, Ding H, Cooper WO. Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy. Am J Obstet Gynecol 2008; 198: 291-295.
-
(2008)
Am J Obstet Gynecol
, vol.198
, pp. 291-295
-
-
Bowen, M.E.1
Ray, W.A.2
Arbogast, P.G.3
Ding, H.4
Cooper, W.O.5
|